11x Secures $24 Million Series A Funding Led by Benchmark to Create the Future of Digital Work
16 sept. 2024 12h00 HE
|
11X AI INC.
11x secures $24 million Series A funding led by Benchmark to create the future of digital work.
SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection
11 sept. 2024 04h51 HE
|
SOLASTA Bio Ltd.
SOLASTA Bio, a leading agri-biotech company specialising in the next generation of green insecticides, has completed an oversubscribed $14 million Series A
Radiance BioPharma sponsoring Investor Cruise Event 2024
29 août 2024 15h30 HE
|
Radiance BioPharma
BOSTON, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Radiance Biopharma Inc., a biopharmaceutical company developing next generation Antibody Drug Conjugates and Bispecific Antibody Drug Conjugates announced...
S64 Announces Successful Close of Series A Funding Round with investments from HPS Investment Partners and Sumitomo Mitsui Trust Bank
29 juil. 2024 03h55 HE
|
S64 Capital
LONDON, July 29, 2024 (GLOBE NEWSWIRE) -- S64, the global alternatives fintech and solutions partner to the wealth management industry, today announced the successful close of its Series A funding...
FUZE Technology Secures $11.5M in Series A Funding to Propel Global Expansion of IoT Hardware and Software
13 juin 2024 08h00 HE
|
FUZE Technology
FUZE Technology (“FUZE”) announces the close of the company's Series A funding round, securing $11.5 million. FUZE also announces adFUZE.
Amber Therapeutics Closes $100 Million Series A Financing to Advance Breakthrough Amber-UI Neuromodulation Therapy for Mixed Urinary Incontinence towards US FDA Approval
10 juin 2024 03h00 HE
|
Amber Therapeutics
US approval would make Amber-UI the first fully implantable adaptive neuromodulation therapy for women with mixed urinary incontinence (MUI)By targeting the pudendal nerve, Amber-UI has the unique...
Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegenerative Ocular Diseases
08 mai 2024 09h00 HE
|
Therini Bio, Inc.
THN391, a mAb designed to block neuroinflammation triggered by fibrin, demonstrated effectiveness in protecting against vascular and neuronal degeneration
Keiretsu Forum Sponsors Quix Labs at the Innovation Funders Showcase During Angel Capital Association's Annual Summit
24 avr. 2024 07h08 HE
|
Keiretsu Forum Mid-Atlantic
Keiretsu Forum Mid-Atlantic, South-East, and Texas regions proudly announce their sponsorship of Quix Labs at the upcoming Innovation Funders Showcase.
Carbon removal firm Captura expands Series A funding to US$45.3M
11 avr. 2024 03h01 HE
|
Captura Corporation
Captura has announced it has further expanded its Series A funding round leading to a total of US$45.3M.
Onum raises $28M to help businesses extract more value from their data at lower costs
10 avr. 2024 08h00 HE
|
Onum
Onum, which gives companies control over their data, cost, and performance, announced today that it has raised a $28 million Series A funding round.